ATE435853T1 - Prostaglandinanaloga - Google Patents

Prostaglandinanaloga

Info

Publication number
ATE435853T1
ATE435853T1 AT05756187T AT05756187T ATE435853T1 AT E435853 T1 ATE435853 T1 AT E435853T1 AT 05756187 T AT05756187 T AT 05756187T AT 05756187 T AT05756187 T AT 05756187T AT E435853 T1 ATE435853 T1 AT E435853T1
Authority
AT
Austria
Prior art keywords
analoga
prostaglandin
compounds
prodrug
useful
Prior art date
Application number
AT05756187T
Other languages
English (en)
Inventor
David Old
Danny Dinh
Robert Burk
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE435853T1 publication Critical patent/ATE435853T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05756187T 2004-07-02 2005-05-31 Prostaglandinanaloga ATE435853T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58514204P 2004-07-02 2004-07-02
US60018004P 2004-08-09 2004-08-09
PCT/US2005/019408 WO2006014206A1 (en) 2004-07-02 2005-05-31 Prostaglandin analogs

Publications (1)

Publication Number Publication Date
ATE435853T1 true ATE435853T1 (de) 2009-07-15

Family

ID=34971749

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05756187T ATE435853T1 (de) 2004-07-02 2005-05-31 Prostaglandinanaloga

Country Status (9)

Country Link
US (1) US7326698B2 (de)
EP (1) EP1765785B1 (de)
AT (1) ATE435853T1 (de)
AU (1) AU2005270229B2 (de)
CA (1) CA2571782C (de)
DE (1) DE602005015323D1 (de)
DK (1) DK1765785T3 (de)
ES (1) ES2327251T3 (de)
WO (1) WO2006014206A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7531533B2 (en) 2005-01-27 2009-05-12 Asahi Kasei Pharma Corporation 6-Membered heterocyclic compound and use thereof
EP2147672A4 (de) 2007-05-08 2011-11-02 Nat University Corp Hamamatsu University School Of Medicine Zytotoxischer t-zellen-aktivator mit einem ep4-agonisten
IT1402047B1 (it) * 2010-10-19 2013-08-28 Cross Pharma Sa Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2452536A1 (de) * 1974-11-06 1976-05-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
EP0020039A1 (de) * 1979-05-23 1980-12-10 Beecham Group Plc Imidazol-Derivate, ihre Herstellung und pharmazeutischen Zusammensetzungen
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US5028624A (en) 1989-07-27 1991-07-02 Allergan, Inc. Intraocular pressure reducing 9,15-diacyl prostaglandins
US5034413A (en) 1989-07-27 1991-07-23 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
CA2021316C (en) 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US4994274A (en) 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
JPH0586034A (ja) 1991-09-27 1993-04-06 Nippon Oil & Fats Co Ltd ヒドロキシル基含有ラクタム誘導体及びその製造方法
WO2002010139A1 (en) * 2000-08-01 2002-02-07 Pharmacia Corporation Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase
US6747037B1 (en) 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs

Also Published As

Publication number Publication date
DE602005015323D1 (de) 2009-08-20
AU2005270229A1 (en) 2006-02-09
US20070054893A1 (en) 2007-03-08
EP1765785A1 (de) 2007-03-28
EP1765785B1 (de) 2009-07-08
WO2006014206A1 (en) 2006-02-09
AU2005270229B2 (en) 2012-04-12
CA2571782C (en) 2012-07-03
DK1765785T3 (da) 2009-11-02
CA2571782A1 (en) 2006-02-09
ES2327251T3 (es) 2009-10-27
US7326698B2 (en) 2008-02-05

Similar Documents

Publication Publication Date Title
ATE440603T1 (de) 8-hydroxychinolinderivate
NO20060408L (no) Fremgangsmate for a modulere kalsium ione-frigjorings- aktivert kalsium ionekanaler
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
CY1110835T1 (el) Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c
HRP20090281T1 (hr) 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti
MX374396B (es) Rocio de fentanilo sublingual.
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
TW200728307A (en) Novel spirochromanone derivatives
WO2007084728A3 (en) 2-imino-benzimidazoles
ATE384058T1 (de) Thiazolderivate
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
MX2009003081A (es) Derivados de pirrola utiles para el tratamiento de enfermedades mediadas por citoquinas.
WO2008008660A3 (en) Cyclopentane derivatives as antiglaucoma agents
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
EA200800302A1 (ru) Применение производных и аналогов тиазола при лечении рака
EA200801199A1 (ru) Ингибиторы киназы
ATE412414T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von proliferativen krankheiten oder entzündungen
WO2007024843A3 (en) Pyrimidinyl-pyrazole inhibitors of aurora kinases
DK1814848T3 (da) 2,3,4-substitueret-cyclopentanoner som terapeutiske midler
WO2006081431A3 (en) Compounds for treating inflammatory and demyelinating diseases
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
SE0200198D0 (sv) New use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties